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Abstract 
Subjects with prehypertension are at risk for developing hypertension (HTN). 
Hypertension is associated with low-grade systemic inflammation (LGSI). Aerobic exercise 
training (ET) is a proven means to reduce both blood pressure and LGSI in healthy and diseased 
subjects. Recently, high intensity interval training (HIIT) has been show to elicit similar 
cardiovascular and metabolic adaptations as ET in healthy and at-risk populations in a more time 
efficient manner. Therefore, we hypothesized that HIIT would elicit greater reductions in blood 
pressure and LGSI than ET. Twelve pre-hypertensive subjects (systolic blood pressure 127.0 ± 
8.5 mmHg; diastolic blood pressure 86.2 ± 4.1 mmHg) were randomly assigned to an ET group 
(n=5) and a HIIT group (n=7). All subjects performed an incremental test to exhaustion 
(VO2max) on a cycle ergometer prior to, after 4 weeks, and after 8 weeks of training. Resting 
heart rate and blood pressure were measured prior to and three times a week during training. 
LGSI was measured via high-sensitivity C-reactive protein (hs-CRP) prior to, after 4 weeks and 
after 8 weeks of training. ET subjects performed an eight week exercise training program at 40% 
VO2 reserve determined from the VO2max test, while HIIT subjects performed exercise at 60% 
peak power determined from the VO2max test. ET group trained four days/week while HIIT 
trained three days/week. ET exercised for 30 minutes continuously at a constant workload and 
cadence of 60 rpm while HIIT performed a protocol on a 1:1 work-to-rest ratio at a constant 
workload and cadence of 100 rpm. Both groups showed similar (p<0.05) decreases in mean 
arterial (ET = -7.3%, HIIT = -4.5%), systolic (ET = -6.6%, HIIT = -8.8%), and diastolic (ET=     
-9.7, HIIT= -8.2%) blood pressure. HIIT decreased in LGSI (-33.7%) while ET did not change 
LGSI (p>0.05). VO2max increased ~25% with both HIIT and ET with no differences (p>0.05) 
  
between groups. These data suggest both HIIT and ET similarly decreased resting blood pressure 
and increased VO2max while HIIT was effective in decreasing LGSI in subjects who were pre-
hypertensive. 
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Chapter 1 - Introduction 
Hypertension (HTN) has been linked to many major chronic diseases. Many diseases, if 
left uncontrolled, may lead to increased mortality. Prehypertension, an elevated blood pressure 
below the clinically diagnosable limit, has been shown to lead to HTN if left uncontrolled. 
However, through various lifestyle changes, factors contributing to elevated blood pressure can 
be well controlled. Exercise training has been shown to elicit beneficial adaptations which lead 
to increased metabolic health and cardiovascular function, including a decrease in elevated blood 
pressure. Traditionally, continuous aerobic exercise training (ET) has been the primary form of 
exercise therapy to achieve beneficial adaptations. However, in recent years, researchers have 
shown high intensity interval training (HIIT) to be a time efficient alternative to achieving 
similar physiological adaptations as ET. Additionally, recent research has shown that low-grade 
systemic inflammation (LGSI) can increase risk for cardiovascular disease including essential 
HTN. It has also been shown that exercise training, primarily high intensity exercise training, can 
decrease levels of LGSI. The majority of research with HIIT has used near-maximal work rates 
which may not be suitable for at-risk or diseased populations. Recently, a practical, low-volume 
interval training protocol has been developed to elicit similar metabolic adaptations as ET in 
subjects at-risk for the development of diabetes. However, this protocol has not been applied to 
other populations, such as hypertensive subjects. Therefore, the purpose of this study was to 
determine the effects of a low-volume, high intensity interval training protocol compared to ET 
on prehypertensive subjects. Additionally, this study investigated the effects of HIIT vs. ET on 
LGSI and how LGSI influenced MAP. 
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Chapter 2 - Literature Review 
 Hypertension 
Normal blood pressure in healthy individuals is a systolic value of ≤120 mmHg and a 
diastolic value of ≤80 mmHg. Hypertension (HTN) is defined as blood pressure elevated from 
normal levels. Physiologically, this includes systolic and diastolic blood pressure higher than 
normal (22). However, HTN is clinically diagnosed when a patient’s blood pressure has 
exceeded a systolic measurement of 139 mmHg and/or a diastolic measurement of 89 mmHg 
(22). HTN is typically classified as either essential or nonessential. Essential HTN is due directly 
to lifestyle choices and is proven to be a highly modifiable risk factor of heart disease, stroke, 
and all-cause mortality (132). Nonessential HTN is a result of a separate disease or disorder that 
has presented itself in the organism, such as renal disease or endocrinal disease. A third category 
of HTN is due to rare genetic disorders (22). This class has no significant contribution to the 
applicable portion of HTN in general population. For the purpose of this study, any reference to 
HTN is in regards to essential HTN unless otherwise noted. 
Hypertension is commonly managed through pharmacological methods. Currently, 68% 
of those diagnosed with HTN are utilizing pharmaceutical therapy for treatment of HTN (90).  
The most widely prescribed type of drug for the control of HTN is an ACE inhibitor, which acts 
by inhibiting the angiotensin-converting enzyme which in turn prevents constriction of blood 
vessels (129). However, the benefits of ACE inhibition and ultimately preventing production of 
angiotensin II may be greater than decreasing blood pressure. In addition to preventing 
production of angiotensin II, ACE inhibitors may also decrease inflammation in the endothelial 
cells of the blood vessels (72). Angiotensin II has been shown to produce a superoxide anion in 
the smooth muscle and endothelial cells of the arterial vessels (54). Furthermore, angiotensin II 
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has been shown to increase the expression of certain pro-inflammatory cytokines (68). By 
increasing systemic cytokine activity there is potential for increasing the risk of HTN and 
cardiovascular disease as there has been strong association between LGSI and cardiovascular 
disease (CVD) risk (135). 
 Essential Hypertension 
Essential HTN has an important economic impact on our nation. In 2008, the United 
States Department of Health and Human Services (USDHHS) reported that 29% of all 
Americans 18 years and older were hypertensive (90). In addition, the asymptomatic nature of 
HTN can cause many of those affected to go undiagnosed (90). Hypertension has severe 
implications aside from direct health outcomes. In 2010, the American Heart Association 
Statistics Committee released an update on heart disease and stroke statistics (75).  Hypertension, 
and outcomes resulting from it, cost the United States $76.6 billion dollars. This included 
medical care, pharmaceuticals, as well as days missed from work due to illness.  With over 50% 
of American adults registering blood pressures above the threshold of healthy, this is a major 
issue in the state of our nation’s health (75). 
Although HTN is dictated greatly by lifestyle choices, there are also other non-modifiable 
factors that contribute to it.  Factors such as age (47, 61, 62), race (15), gender (57), and familial 
history (82, 115) all have a role in the development of HTN. However, these factors are 
uncontrollable and unavoidable.  In 2004, the Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure listed several lifestyle 
choices that could increase the risk of HTN including: excess body weight (obesity), excess 
dietary sodium intake, reduced physical activity, tobacco and alcohol use (22).  In addition, this 
report indicates that primary prevention methods should aim to reduce or remove the lifestyle 
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factors associated with elevated blood pressure (22). Studies have suggested that a 2 mmHg 
reduction of diastolic blood pressure could cause a 17% decrease in the prevalence of HTN, a 
14% reduction in mortality due to stroke and 9% reduction due to coronary heart disease leading 
to a 7% decrease in all-cause mortality nationally (26, 114, 132).  Given that known lifestyle 
changes affect HTN, a greater emphasis on increasing physical activity and exercise is an 
attractive intervention. 
 Prehypertension 
Prehypertension is clinically classified as having a systolic blood pressure in the range of 
120-139 mmHg and/or a diastolic pressure between 80-89 mmHg (18).  That is, a blood pressure 
elevated from what is considered normal or healthy, but not high enough to be clinically 
diagnosed as HTN. The term prehypertension was recently created in an effort to emphasize the 
clinical importance of this range of blood pressures (22). The rationale for this renaming was due 
in large part to the tendency for blood pressure to increase with age in industrialized society 
(120). The USDHHS reported an additional 28% of US adults being prehypertensive in addition 
to those diagnosed with HTN (90). Although there is often no clinical diagnosis for 
prehypertension, it remains a health issue. Researchers have shown in longitudinal data that men 
and women who were non-hypertensive at ages 55-65 had a 90% chance of becoming 
hypertensive if they lived to be 80-85 years old (126). More importantly, people who are 65 
years or older have a 50% and 26% chance of becoming hypertensive in the next four years if 
they have blood pressures of 130-139/85-89mmHg and 120-129/80-85mmHg, respectively 
(127).  
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 Prehypertension and Disease 
Health is a continuum: optimal health on one end and severely unhealthy on the other 
end. With regards to blood pressure, if one does not clinically qualify as hypertensive, s/he may 
still in fact be unhealthy and at increased risk of disease. Lawes et al (2008) quantified the 
positive correlation that chronic disease has to above normal blood pressure (71). These authors 
found that high blood pressure, prehypertension and HTN, contributed to stroke (54% of 
subjects), ischemic heart disease (47%), hypertensive disease (75%) and other CVD (25%).  
Unfortunately, since prehypertension is not a diagnosable disease or disorder, subjects are still 
considered “healthy” while being at risk and have to wait for the onset of HTN or one of the 
other related diseases before treatment is prescribed. Qureshi et al (2005) similarly determined 
significant associations between prehypertension and cardiovascular disease (98). Of the over 
5,000 prehypertensive subjects who participated in the Framingham Study, none had experienced 
myocardial infarction or stroke at the baseline measurement. Using 10 year follow up 
measurements, Qureshi and colleagues (2005) drew statistically significant associations between 
prehypertension and both myocardial infarction and coronary artery disease (98).   
 Blood Pressure and Aerobic Exercise Training 
In 1992, The American Heart Association released a position statement describing the 
benefits of regular aerobic activity on hypertensive subjects (42). These benefits included 
controlling abnormalities in blood lipid levels and carbohydrate metabolism, increasing 
maximum ventilatory oxygen uptake and, specifically relating to cardiovascular health, 
beneficial changes in hemodynamic function such as increased vascular conductance (42). More 
recently, Whelton and colleagues (2002) published a meta-analysis of 53 randomized, controlled 
studies conducted between 1986 and 2000 to determine the effect of aerobic exercise on blood 
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pressure (133). In 45 supervised studies, a net decrease in both systolic and diastolic blood 
pressures, 4.23 and 2.68 mmHg respectively, was reported. Importantly, of the 53 studies 
analyzed, 27 studied participants who were not hypertensive, but likely prehypertensive (133).  
 High Blood Pressure and Aerobic Exercise Training 
The beneficial effects of aerobic exercise on the control of blood pressure have been well 
researched (30, 38, 46, 64, 133). Researchers have shown that exercise at various intensities can 
alter many mechanisms responsible for reduced heart rate (3, 32, 33, 46, 137), increased stroke 
volume (25, 46, 89) and/or decreased total peripheral resistance (17, 46, 78, 113, 134). Aerobic 
exercise helps reduce resting heart rate, primarily through an altering of the parasympathetic and 
sympathetic outflows (3, 32, 33, 137). After exercise in healthy subjects there is an increase in 
vagal tone representing an increase in parasympathetic outflow (32). In unhealthy subjects, a 
decrease in sympathetic outflow occurs in addition to an increase in parasympathetic outflow, 
furthering the reduction in heart rate (3, 33). Along reduction in heart rate, stroke volume will 
increase due to an increase in production of plasma proteins and the Frank-Starling mechanism 
(25, 89).  The primary effect of exercise on blood pressure is due to a reduction in total 
peripheral resistance (46). The mechanisms involved with a decrease in vascular resistance are 
likely norepinephrine and endothelial-1, both potent vasoconstrictors (17, 78, 113, 134). More 
recently, nitric oxide production and synthesis in the endothelial cells lining the vessels have 
shown to be significantly beneficial (65, 96). It is apparent, during various modes, intensities and 
durations of exercise, that aerobic exercise is beneficial to maintain or improve cardiovascular 
function, including HTN. 
More recently, LGSI has been reported as a possible mechanism of atherosclerosis and 
vascular dysfunction (72, 79, 91, 135). In a sclerotic state, the vessel will have less compliance 
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leading towards a higher pressure as each pulse wave pushes through the vessel. Thus, it is 
important to consider LGSI as factor when discussing possible mechanisms involved in HTN. 
 Acute and Low-Grade Systemic Inflammation 
Acute inflammation is a component of the non-specific immune response that occurs in 
response to injury or disease. In most cases inflammatory responses are self-limiting in which the 
body is able to regulate the levels of inflammation reached. However, some cases of 
inflammation cannot be controlled and result in chronic inflammatory diseases (39).  Symptoms 
of acute inflammation are pain, heat, redness, swelling, and loss of function. Pain will only occur 
at the site of inflammation if the appropriate sensory nerves are present (20). The inflammatory 
response can involve many various plasma and cellular derived substances known as cytokines. 
The term cytokine refers to a large family of regulators produced throughout the body by many 
different cells (50). In the context of this paper, cytokine will refer to a modulator of the immune 
system. Often, an adverse reaction to an increase in cytokine activity is local inflammation. 
Sepsis is the classic model for researching this type of cytokine activity. In these models, after 
introduction of an inflammatory stimulus, the cytokines appear and can be detected systemically 
in the following order: tumor-necrosis factor alpha (TNF-α), Interleukin-1 beta (IL-1β), 
Interleukin-6 (IL-6), Interleukin-1 receptor antagonist (IL-1ra), Interleukin-10 (IL-10), and 
soluble TNF- α receptors (sTNF-R) (2). 
More recently, it is generally believed that a low-grade systemic inflammatory response 
is a primary process in the generation of conditions such atherosclerosis, obesity, type-2 diabetes 
and HTN (91). Low-grade systemic inflammation consists of elevated levels of the cytokines 
TNF-α, IL-1β, IL-6, IL-1ra and sTNF-R (2, 31, 36, 72). Unlike sepsis, which elicits an 
exponential rise in cytokine activity of up to 100-fold, LGSI elicits a smaller two or three fold 
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response (95). The exact stimuli for cytokine production causing LGSI are unknown (27). It is 
hypothesized that atherosclerosis can be attributed to an accumulation of macrophages below the 
endothelial cells in blood vessels (36, 72). The accumulation of cells potentially causes an 
increase in external pressure as well as a decrease in local vascular health resulting in increased 
pressure and a less compliant vessel. 
 Exercise Induced Inflammation 
As inflammation is the response to damaged tissue, certain inflammatory cytokines are 
also produced during exercise. However, unlike infections or LGSI, there is no initial increase in 
TNF- α or IL-1during the inflammatory response. The first cytokine present during exercise is 
IL-6, which increases similar to values seen during the acute phase response (95). The release of 
IL-6 during exercise stimulates the release of IL-1ra, IL- 10 (116), and sTNF-R, but not IL-1β or 
TNF-α (123). In addition, IL-6 appears to be the primary factor inducing the release of 
hepatocyte-derived acute-phase proteins having anti-inflammatory properties (1). Despite the 
many cytokines involved in the pro- and anti-inflammatory responses, there is a single protein, 
C-reactive protein, which serves as a marker of inflammation not apparent until 8-12 hours 
following an inflammatory stimulus (95). 
 C-reactive Protein (CRP) 
C-reactive protein (CRP) is an acute phase protein produced by hepatocytes and is 
circulating in all humans with levels that rise in response to inflammation. It was the first acute-
phase protein to be discovered as a systemic marker of inflammation (92). In healthy humans, 
the mean level of CRP is 0.8 mg/L of blood, with the 90
th
 centile at 3.0 mg/L. In an acute-phase 
stimulus, such as infection, levels can potentially increase up to 10,000 times baseline levels 
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(111), although an increase in CRP is not seen in the inflammatory response to exercise (95). 
During the acute-phase stimulus, CRP typically rises above normal limits within 6 hours, and 
peaks at 48 hours following event. The half-life of CRP is 19 hours in both healthy and inflamed 
states, thus the only determining factor of circulating CRP is the rate of synthesis which directly 
reflects the intensity of the stimulating process (128).  Circulating CRP levels have no circadian 
rhythm (77) but may be influenced by certain diets (102). Reductions in CRP have been shown 
under low-carb (108), high plant sterols (60), alpha-linoleic acid rich (7), and Mediterranean 
style diets (37) while there has been a positive correlation made between CRP levels and 
glycemic load (74). Liver failure directly impairs CRP production due to impairment of 
hepatocytes. However, very few drugs affect CRP levels unless they also affect the pathological 
event initiating the acute-phase stimulus. Due to the resiliency of CRP, it serves as a very useful 
nonspecific marker of inflammation (92). In a clinical setting, the measurement being made is of 
high-sensitivity CRP (hs-CRP) (105). Many times these two types of proteins will be used 
interchangeably when discussing the relationship between systemic inflammation and risk of 
cardiovascular disease. The primary difference between CRP and hs-CRP is the measurement 
techniques used with hs-CRP are able to measure it in much lower levels allowing for greater 
detection of LGSI (5). 
 CRP as a Cardiac Risk Factor 
Recently in the scientific literature there has been debate if elevated CRP can be 
considered a risk factor or a risk marker of cardiovascular disease (135). The American Heart 
Association (AHA) and Center for Disease Controls (CDC) issued a statement regarding the use 
of CRP as a risk factor for CVD (91). In the statement is a set of criteria which the AHA and 
CDC use to describe desirable characteristics of a risk factor. Such criterion includes statistical 
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relevance as well as the ability to standardize testing and costs to the public. Of the various pro-
inflammatory substances, the statement lists CRP as the best available test for assessing risk of 
CVD (91). In 1997, Ridker et al. conducted a longitudinal study hypothesizing that the risk of 
myocardial infarction and stroke, but not of venous thrombosis, was positively correlated to the 
baseline levels of CRP (104). The authors found that subjects with baseline values in the quartile 
with the highest levels of CRP had a higher relative risk for myocardial infarction and ischemic 
stroke than those in the lowest quartile. Thus, Ridker et al. (1997) concluded that there is a 
positive association with CRP and future cardiac events. Although systemic inflammation shows 
statistical associations with CVD risk, for clinical applications it would need to be validated 
against current measures. Ridker et al. (2000) conducted a longitudinal case-study of post-
menopausal women assessing baseline levels of five different inflammatory markers as well as 
several lipid and lipoprotein measurements. These authors found, of all the markers measured, 
CRP was the strongest predictor of risk, greater than the more common measurement of ratio of 
total cholesterol to high-density lipoprotein (HDL), when compared as the lowest-quartile. In 
addition to current common measurements, based off the results of this study, measuring CRP 
levels in a clinical setting would better predict risk for cardiovascular events (101). 
 CRP and Hypertension 
It has been well documented that HTN is a major risk factor associated with many of the 
leading causes of death due to disease (84). As mentioned, it has recently been shown that 
systemic inflammation may be related to atherosclerotic vessels (36). According to Poiseuille's 
Law, pressure is related to the radius of the cylinder that the fluid is moving through. With a 
hardened vessel wall, a less compliant vessel wall, the pressure will increase. In the 
cardiovascular system, this would result in an increase of blood pressure. Using data from one of 
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the most in-depth cardiovascular studies, the Framingham study, Ridker and colleagues (2000) 
made the observation that hs-CRP levels was the strongest predictor of future development of 
cardiovascular disease, including HTN, when compared to more common measurements such as 
total LDL cholesterol, total HDL cholesterol, and nine others (101). It has also been observed 
that the common pharmacological statin therapy has no effect on systemic inflammation in 
sclerotic vessels, although a reduction in LDL cholesterol can be seen (72) thus, leaving the 
vessel in a fibrotic state which still leads to HTN although in absence of hyperlipidemia. It has 
also been suggested that since total cholesterol and CRP act independently, hs-CRP assays may 
detect a different population at-risk leading to greater overall prediction of cardiovascular disease 
(135). In a clinical state, with the availability of hs-CRP assays, researchers have suggested 
adding it to the spectrum of blood tests done due to the cost-effectiveness in aiding the detection 
of possible disease (102, 103).  
 CRP and Aerobic Exercise Training 
As aerobic exercise training has been shown to lower blood pressure, a common risk 
factor for CVD, decreases in markers of systemic inflammation can be seen post-exercise (80, 
81, 119). Mattusch et al. (2000) studied moderately trained runners who were preparing for a 
marathon. The subjects trained 3-4 times per week, each session lasting 50 minutes at 
approximately 75% of the subject’s lactate threshold. Mattusch found a decreased baseline CRP 
concentration in 10 of the 12 runners who completed training. This was contrary to the proposed 
hypothesis but strengthens the idea that exercise elicits an anti-inflammatory effect (80). Also, 
Stewart et al. (2007) conducted an exercise training study using treadmill running at 70-80% of 
heart rate reserve for 20 minutes in combination with a resistance training program that elicited 
momentary fatigue.  Their subject pool consisted of both older and younger (71 ± 4 and 25 ± 5 
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years, respectively) who were classified as both active and inactive via self-report measures 
(119). The authors found a 58% decrease in serum CRP levels in the physically inactive subjects 
with no change in the active subjects, demonstrating that similar effects occur across different 
ages. Exercise-induced decreases in systemic inflammation can be seen in subjects who have 
already or currently have cardiovascular disease as well. Milani et al. recruited 235 subjects 
already suffering from coronary heart disease into a rehabilitation program that consisted of 
dietary controls and exercise training for three months (81). After three months, Milani et al. 
reported a similar decrease in CRP levels for subjects on and off of statin therapy, 42% and 38% 
respectively. The authors concluded that CRP, independent of other factors associated with 
exercise, will decrease significantly in subjects with coronary heart disease.  
 High-intensity Interval Training 
Current American College of Sports Medicine (ACSM) guidelines state that the 
recommended amount of cardiorespiratory exercise training is at least 30 min/day on at least five 
days/week of moderate intensity or at least 20 minutes a day on three days/week of vigorous-
intensity exercise for maintaining a healthy level of cardiorespiratory fitness (48). Previous 
studies have shown that brief, intense bouts of exercise elicit similar mitochondrial enzymatic 
responses (107), reduce glycogen utilization and lactate accumulation during matched-work 
exercise (12, 13), and can improve performance of activities heavily reliant on aerobic 
metabolism (34). Interval training, therefore, may be a time-efficient alternative to endurance 
training to present guidelines for healthy cardiorespiratory and metabolic adaptations (28).  
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 Chronic Training Adaptations 
High intensity interval training (HIIT) leads to many chronic adaptations. Chronic 
interval training protocols of various lengths, ranging from as short as six sessions over a two 
week span up to four sessions a week for 13 weeks, have increased maximal oxygen uptake (14, 
23, 44, 55, 58, 59), decreased submaximal (44) and maximal exercising heart rate (23, 44), and 
increased time to fatigue (12-14). Though exercise protocols differed, similar mechanisms were 
triggered to cause the responses. Previous literature suggests the increase in oxygen uptake from 
training is intensity-dependent (52). Training bradycardia was possibly related to fewer afferent 
impulses arising (24) or an increase in stroke volume leading to a greater cardiac output per 
minute (58).  The increased time to fatigue may be due to an increased efficiency (58) or in 
metabolic processes (12-14).  Future research is still required to determine specific mechanisms 
responsible for these adaptations with HIIT. Although the optimal training protocol is still 
unknown, the benefits of HIIT training are apparent in the literature. However, it is less clear if 
similar benefits occur in at-risk or diseased populations or if this population is able to tolerate 
high intensity interval training. 
 Interval Training for At-Risk Populations 
Although benefits of interval training have been reported in healthy populations (12-14, 
44, 58), it is unclear if an at-risk population would be able to comply with vigorous bouts of 
exercise. Several studies using the similar volume of exercise (12-14, 73) used exercise protocols 
with very high intensities (~100% VO2max) that would be far too difficult, and possibly 
dangerous for certain at-risk or diseased populations to perform. Specific with regards to HTN, 
ACSM has released a separate recommendation for cardiorespiratory maintenance calling for a 
lower intensity of exercise due to their potentially weakened cardiovascular system (94).  
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However, recent studies have shown potential for interval training to serve as a means to 
decreasing factors involved in the development or increasing the ability to manage HTN (23). 
As mentioned earlier, a prehypertensive individual is considered at-risk for HTN and 
cardiac events due to the tendency for an increase of mean arterial pressure over time (120). 
Interval training has been shown to decrease risk factors in normotensive at-risk women (23), 
subjects who had already suffered a cardiovascular event (55, 136), and subjects undergoing 
cardiac rehabilitation (130). Exercise training elicited improvements in central and peripheral 
cardiovascular function (23, 55, 136), exercise tolerance (136), and increased aerobic capacity 
(55, 136). Additionally, subjects showed increases in submaximal values in VO2, ventilation and 
exercising heart rate during the interval protocol (55) which potentially would all benefit 
individuals with HTN. According to the guidelines previously mentioned, these exercise 
protocols meet the recommended time commitment necessary to cause cardiovascular benefits. 
ACSM guidelines also state the primary barrier for noncompliance is the issue of time 
commitment (48). Assuming subjects who have or are nearing disease are not meeting the 
current guidelines, it is appropriate to explore even more time efficient means of reaching the 
physiological adaptations of the currently suggested exercise guidelines.  
Hood et al. (2011) recently developed a low-volume interval training protocol tailored to 
sedentary, at-risk adults (59). Although not necessarily meeting the recommendations put forth 
by the ACSM, Hood and colleagues’ protocol induced metabolic adaptations that reduced the 
risk of inactivity-related disorders in middle-aged adults who, prior to participation in the study, 
were considered sedentary (59). Although previous studies from their lab had shown similar 
results (73), their study remained novel because the subjects were middle-aged (45 ± 5 years) 
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sedentary subjects. The relative intensity was similar to a study by Guirard et al.  (2011), 
suggesting that this is a safe protocol to exercise for at-risk as well as diseased populations.  
In summary, prehypertension and HTN have many important health risks. It is known 
that aerobic exercise is a beneficial means of preventing and reversing the effects associated with 
HTN. Additionally, elevated levels of systemic inflammation are associated with increased 
prevalence of HTN and other cardiovascular risks. Previous literature also shows the benefits of 
aerobic exercise in relation to systemic inflammation. Recent evidence suggests possible 
cardiovascular benefits are associated with HIIT. In particular, an intriguing possibility exists for 
HIIT in managing HTN and determining how it compares with more conventional exercise 
approaches. Therefore, the purpose of this study was to determine the effects of high intensity 
interval training versus continuous aerobic exercise on subjects with prehypertension. 
Additionally, we were interested in examining the influence of HIIT on LGSI and how this 
contributes to possible changes in blood pressure. We hypothesized that, due to the increased 
benefits seen with increased intensities, HIIT would show a greater decrease in mean arterial 
pressure than endurance training in pre-hypertensive subjects. In addition, due to greater 
reductions seen during high intensity exercise, we hypothesized HIIT would show a greater 
decrease in hs-CRP levels than endurance training in the same population.  
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Chapter 3 - Methods 
 Subjects 
Fifteen pre-hypertensive subjects (3 men; 12 women) with elevated blood pressures 
(SBP: ≥120mmHg, DBP: ≥80mmHg) volunteered to participate. After being informed of the 
risks, subjects signed an informed consent waiver. No subjects had been previously diagnosed 
with clinical HTN and were apparently healthy as determined by standard pulmonary function 
tests and medical history questionnaire. All subjects were non-smokers, inactive (did not train at 
least one month prior to volunteering), and were free of heart and pulmonary disease determined 
via questionnaire. During the course of the study, three subjects dropped out due to schedule 
conflicts (n=2) and injuries not associated with this study (n=1). Therefore, a total of 12 subjects 
completed the protocol and were used in analysis. Subjects were encouraged to maintain their 
normal lifestyle, activity, and diets throughout the training period. All procedures were approved 
by the Institutional Review Board at Kansas State University, Manhattan, KS. 
 Experimental Design 
The experimental protocol consisted of baseline testing, an 8-week training intervention, 
and post-training testing. Subjects visited the laboratory four times prior to training (BASE), 24-
32 times for training sessions, and three times after the final session of training (POST). During 
the first visit, measurements of resting pulse rate and blood pressures, both systolic and diastolic, 
were performed. On the second visit, pulmonary function tests (PFT), an incremental maximum 
oxygen uptake test (VO2max) was performed in addition to blood samples taken for the 
measurement of systemic inflammation (high-sensitive C-reactive protein (hs-CRP)). Height, 
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weight, blood pressure, and pulse rates were measured the following visit. Following baseline 
testing, subjects were randomly assigned to either a high intensity interval training group (HIIT: 
n=7) or endurance training group (ET: n=5). Within four days, subjects performed a 
familiarization session of their designated training protocol and began an 8-week training period. 
Upon completion of training, subjects repeated visits two through four. After four weeks of 
training, subjects completed a VO2max test in order to adjust the workload if necessary for any 
training effect. 
 Exercise Training 
The training protocol was initiated at least two days following the familiarization bout. 
All subjects completed eight weeks of training. Both groups followed a standardized warm-up of 
three minutes pedaling at a cadence of 60rpm at 50% of the training workload. Specifically the 
training protocol used is one that has been previously used in an at risk population (59). Subjects 
following the ET protocol exercised four days a week, with at least two sessions per week being 
non-consecutive (i.e. training occurred on Monday, Tuesday, Thursday and Friday each week). 
Subjects completed 30 minutes of exercise at a workload equivalent to the 40% VO2 reserve 
(VO2R) on the cycle ergometer (Monark 818E) at a maintained cadence of 60 rpm. Subjects in 
the experimental group followed a HIIT protocol that has previously been used in at risk 
populations (73). Subjects performed a 1-to-1 work-to-rest ratio lasting 120 s on the cycle 
ergometer (Monark 828E). The bout was performed 10 times each session. The workload was set 
to 60% of peak power achieved during the VO2peak test. Following the termination of a session, 
subjects were allowed to cool-down at their own discretion, with workloads never being more 
than 50% of the training workload and never extending beyond five minutes. All training took 
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place in an exercise training lab within the Department of Kinesiology at Kansas State University 
and sessions were directly supervised. 
 Experimental Measurements  
 Maximal Aerobic Capacity 
The incremental maximal oxygen uptake test was performed on a cycle ergometer 
(Sensormedics 800). Metabolic and ventilatory data were collected and analyzed continuously 
breath-by-breath throughout exercise (Sensormedics 229 Metabolic Cart, Sensormedics Corp., 
YorbaLinda, CA). A pulse oximeter (Datex-Ohmeda 3900P, Madison, WI) was used to estimate 
arterial oxygen saturation (SpO2). Heart rate (HR) was continuously monitored via a chest strap 
heart rate monitor (Polar T31-Uncoded, Polar). Values from the modified Borg’s rating of 
perceived exertion scale (RPE), measured 1-10, were recorded at each stage of exercise. After 
three minutes of rest, subjects began to warm up with unloaded cycling for one minute 
maintaining a cadence of 60-80 rpm. Following the warm up, the workload was increased by 
25W every minute. Exercise was terminated when the subject was unable to maintain a cadence 
of 50 rpm for six seconds. All subjects were verbally encouraged to complete the test at the 
highest work rate possible. This value established the subject’s peak oxygen consumption 
(VO2peak). 
Upon the termination of testing, subjects were removed from the ergometer for 15 
minutes before attempting a second bout for validation of VO2max.  During the validation test, 
subjects began cycling at a cadence of 60-80 rpm while a workload equal to 110% of that 
reached previously was rapidly set.  Subjects were encouraged to pedal until exhaustion, 
maintaining a cadence of 60-80 rpm.  
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 Blood Sampling and Biochemical Analysis 
Subjects sat quietly for five minutes before sample collection. Blood samples were 
collected via finger stick from the middle finger on their non-dominant hand. Prior to collection, 
the instrument was calibrated and subjects washed their hands with warm water and had their 
fingers massaged from the base to the tip several times.  The finger stick site was then cleaned 
with alcohol and dried with a gauze pad.  50μm blood samples were collected in sterile lithium 
heparin coated capillary tubes within 10 seconds. hs-CRP was determined from whole blood 
samples which were applied to an  hs-CRP cassette (Alere Cholestech LDX hs-CRP cassette, 
Alere San Diego, Inc., San Diego, CA). The cassette was then placed in the analyzer (Alere 
Cholestech LDX Analyzer, Alere San Diego, Inc., San Diego, CA) where the plasma was 
separated from the blood cells. Plasma was then incubated with a colloidal gold anti-CRP 
conjugate. The conjugate containing hs-CRP is captured by antibody while the remainder of the 
conjugate was discarded. A magnetic strip found on each cassette allowed the analyzer to 
calibrate and convert the reflectance reading (%R) to an hs-CRP concentration (mg/L). 
 Blood Pressure Measurements 
Blood pressure measurement was taken at the brachial artery via manual 
plethysmography. Subjects were seated for at least 10 minutes at the time of measurement. 
Measurements were taken on three non-consecutive days each week for the entirety of the study. 
All measurements were made by the same researcher. A second researcher also made 
measurements during the pretesting, midpoint testing, and post testing phase to validate the 
original measures. 
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 Statistical Analysis 
SigmaStat 10 Statistical Software (Systat Software, Chicago, IL) was used for data 
analysis. Data is expressed as mean ± SD. Statistical comparisons were corrected for unequal 
sample size by Bonferonni adjustment. Group differences were determined by a two-way mixed 
ANOVA with time as a repeated measurement. Relationships were determined via Pearson 
Product Moment Correlation. Significance was set at p < 0.05 for all analyses. 
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Chapter 4 - Results 
 Subjects 
Subject characteristics are shown in Table 1. The men-to-women ratio was similar 
between groups (endurance training: m = 1, f = 4; high intensity interval training: m = 2, f = 7). 
There were no differences (p>0.05) in age, height, weight, or body mass index between groups 
  
Table 1: Subject Characteristics 
 ET (n=5) HIIT (n=7) 
Age (yrs) 33.8 ± 2.0 33.0 ± 7.4 
Height (cm) 164.4 ± 6.2 170.6 ± 8.1 
Weight (kg) 75.8 ± 13.0 86.0 ± 13.7 
BMI (kg/m
2
) 28.3 ± 5.2 29.5 ± 3.8 
MAP (mmHg) 98.4 ± 2.5 100.6 ± 5.4 
Systolic Blood Pressure (mmHg) 124.2 ± 7.6 128.8 ± 8.2 
Diastolic Blood Pressure (mmHg) 85.5 ± 1.5 86.5 ± 4.3 
hs-CRP (mg/dL) 2.0 ± 1.7 3.2 ± 2.6 
VO2max (mL/kg/min) 22.9 ± 1.6 23.8 ± 3.5 
HRrest (bpm) 79.2 ± 10.0 81.1 ± 8.5 
Values are presented as mean ± SD 
hs-CRP = high-sensitivity C-reactive protein 
MAP = mean arterial pressure 
 
 Training 
Training adherence was 100% for all subjects across all training sessions. The total time 
per training week for HIIT (39 minutes) was 29.6% of time spent training by ET (132 minutes). 
Average training heart rate for both groups is shown in Table 2. By design, HR values were 
significantly higher for HIIT compared to ET throughout training. The workload averaged 80.5 ± 
23.3W (range 50-135W) for ET and 119.6 ± 24.3W (range 90-165W) for HIIT. Average 
intensity during training was ~68% VO2max during ET and ~93% VO2max during HIIT. The 
average amount of work per week was over two times greater (p<0.05) in ET (579.6 ± 41.9kJ) 
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than in HIIT (215.3 ± 14.6kJ). Height, weight and body mass index did not change (p>0.05) with 
training. 
 
Table 2: Exercising Heart Rate 
 Day 1 Day 2 Day 3 Day 4 Average 
Endurance      
Week 1 140.2 ± 15.7 143.9 ± 15.5 141.2 ± 20.2 139.0 ± 19.8 141.1 ± 2.1 
Week 2 139.0 ± 17.9 141.0 ± 17.0 137.0 ± 17.6 132.2 ± 15.0 137.3 ± 3.8 
Week 3 134.8 ± 13.7 139.4 ± 13.4 131.5 ± 15.5 134.1 ± 16.8 134.9 ± 3.3 
Week 4 131.8 ± 12.4 135.8 ± 16.4 130.4 ± 15.3 128.9 ± 20.0 131.8 ± 2.9 
Week 5  147.3 ± 17.6 150.1 ± 20.2 143.7 ± 18.0 147.1 ± 3.2 
Week 6 136.4 ± 19.1 137.6 ± 15.3 137.6 ± 20.4 136.3 ± 16.3 137.0 ± 0.7 
Week 7 131.8 ± 15.8 137.4 ± 16.6 138.5 ± 22.2 136.2 ± 16.8 136.0 ± 3.0 
Week 8 142.6 ± 16.8 137.7 ± 16.9 141.5 ± 19.8 142.9 ± 17.5 141.2 ± 2.4 
HIIT      
Week 1 165.6 ± 19.4 169.7 ± 20.5 161.4 ± 18.5  165.6 ± 4.2* 
Week 2 157.5 ± 17.1 156.8 ± 17.4 155.6 ± 17.8  156.6 ± 0.9* 
Week 3 156.6 ± 16.9 145.8 ± 20.0 150.8 ± 25.8  151.1 ± 5.4*^ 
Week 4 156.4 ± 17.5 150.8 ± 23.0 151.7 ± 18.0  153.0 ± 1.7*^ 
Week 5  160.5 ± 15.9 157.2 ± 16.3  158.9 ± 1.4 
Week 6 153.0 ± 15.5 153.5 ± 13.9 159.9 ± 17.3  155.5 ± 2.2* 
Week 7 157.4 ± 17.6 155.2 ± 14.2 155.1 ± 13.6  155.9 ± 0.8* 
Week 8 153.8 ± 17.0 156.0 ± 16.1 153.3 ± 19.2  154.4 ± 0.8* 
Values are presented as mean ± SD 
*significantly different from ET; p <0.05 
^significantly different from Week 1; p<0.05 
Note: Week 5, Day 1 is blank due to subjects performing a VO2max test that session. HIIT was 
limited to three days a week so there are no Day 4 values. 
 
Arterial Blood Pressure 
Table 3 shows ET and HIIT resting blood pressures and resting heart rates for pre-, after 
4 weeks and after 8 weeks. Figure 1 shows the individual and mean responses of resting mean 
arterial pressure prior to, after 4 weeks and after 8 weeks of training. Figure 2 shows individual 
and mean responses of systolic blood pressure (SBP) prior to, after 4 weeks and after 8 weeks of 
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training. Figure 3 shows individual and mean responses of diastolic blood pressure (DBP) prior 
to, after 4 weeks and after 8 weeks of training. Groups were well matched with no significant 
differences in their baseline values. Both training groups showed similar (p<0.05) reductions in 
MAP from baseline of -4.5 to -7.3% (5 of 5 subjects in ET and  6 of 7 subjects in HIIT) at 4 
weeks and 8 weeks. After 4 weeks of training, reductions in SBP of ~5% from baseline occurred 
in 5 of 5 subjects in ET and 6 of 7 subjects in HIIT. There was a further decrease (p<0.05) in 
HIIT after the week 8, but not (p>0.05) in ET. DBP decreased (p<0.05) during the fourth week 
of training in ET but not (p>0.05) with HIIT. After week 8, DBP decreased significantly from 
baseline in HIIT with no further (p>0.05) decrease from week 4 in ET. The weekly averages of 
MAP (Figure 4A), SBP (Figure 4B), and DBP (Figure 4C) are shown for both ET and HIIT. At 
week 7, DBP was significantly higher in HIIT compared to ET. No difference occurred at any 
other time (p>0.05). 
Table 3: Blood Pressure 
 ET (n=5) HIIT (n=7) 
 Pre 4 Weeks 8 Weeks Pre 4 Weeks 8 Weeks 
MAP (mmHg) 98.4 ± 2.5 91.2 ± 5.5* 87.7 ± 7.7* 101.0 ± 6.2 96.5 ± 5.8* 92.4 ± 5.6* 
SBP (mmHg) 124.2 ± 7.6 116.0 ± 6.2* 112.4 ± 8.8* 129.0 ± 9.2 123.1 ± 6.8* 117.7 ± 7.0^ 
DBP (mmHg) 85.5 ± 1.5 77.2 ± 5.8* 73.6 ± 7.4* 86.8 ± 5.3 83.1 ± 5.6 79.7 ± 6.2* 
HRRest (bpm) 79.2 ± 10.0 66.6 ± 8.8* 65.8 ± 6.7* 81.1 ± 9.2 75.9 ± 9.2 71.6 ± 9.5* 
PP (mmHg) 38.8 ± 8.1 38.0 ± 3.7 38.4 ± 1.7 42.2 ± 5.1 38.7 ± 4.2 38.0 ± 6.7 
Values are presented as mean ± SD 
*significantly different from Pre; p<0.05 
^significantly different from 4 weeks; p<0.05 
MAP = mean arterial pressure, SBP = systolic blood pressure, DBP = diastolic blood pressure, 
HRRest = resting heart rate, PP = pulse pressure 
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Figure 1: Mean Arterial Pressure 
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 Fig. 1: Individual (open circles) and mean (filled diamonds) MAP responses to training. Both 
ET and HIIT showed similar decreases at 4 wks. from baseline (approximately -7.3% and -4.5% 
respectively, p<0.05) with no further decrease at 8 wks. 
* significantly different from Pre; p<0.05 
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Figure 2: Systolic Blood Pressure 
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Fig. 2: Individual (open circles) and mean (filled diamonds) systolic blood pressure responses to 
training. Both ET and HIIT showed similar decreases at 4 wks. from baseline (approximately -
6.6% and -4.6% respectively, p<0.05). HIIT showed a further decrease at 8 wks. from 4 wks. 
(approximately -4.4%, p<0.05) while ET show no further decrease. 
* significantly different from Pre; p<0.05 
+ significantly different from 4 weeks; p<0.05 
^ significantly different from ET; p<0.05 
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Figure 3: Diastolic Blood Pressure 
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Fig. 3: Individual (open circles) and mean (filled diamonds) diastolic blood pressure responses to 
training. ET showed a decrease at 4 wks. from baseline (approximately -9.7%, p<0.05) with no 
further decrease at 8 wks. HIIT showed a decrease at 8 wks. from baseline (approximately -
8.2%, p<0.05). 
* significantly different from Pre; p<0.05 
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Figure 4: Weekly Average Mean Arterial Blood Pressure 
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Fig. 4: Group mean time course for mean arterial pressure (A), systolic blood pressure (B), and 
diastolic blood pressure (C). Fig. 4A: There were no group differences (p>0.05) during training. 
Fig. 4B: There were no group differences (p>0.05) during training. Fig. 4C: ET had a 
significantly greater decrease from Week 6 to 7 than HIIT (approximately -4.6% and 0% 
respectively, p<0.05). All other times were not different (p>0.05) between groups. 
* significantly different from ET; p<0.05 
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 Systemic Inflammation 
Table 4 shows mean ET and HIIT high-sensitivity C-reactive protein, as a marker of 
systemic inflammation levels, for pre-, 4 weeks and after 8 weeks. Figure 5 shows individual 
(open circles) and mean (closed circles) CRP responses over the course of training. There was no 
difference (p>0.05) between groups prior to training. There was a decrease (p<0.05) in hs-CRP 
after 4 weeks and after 8 weeks from baseline in HIIT with no changes (p>0.05) in ET after 4 
weeks or after 8 weeks. There was no relationship (r=0.04) between the decrease in hs-CRP 
(p>0.05) and change in MAP. Additionally, there was no relationship (r=0.09) between baseline 
levels of hs-CRP (p>0.05) and MAP in the subjects. This is not in agreement of previous 
literature using crossover data from an epidemiological approach. 
 
Table 4: High-sensitivity C-reactive Protein 
 ET (n=5) HIIT (n=7) 
Pre 1.97 ± 1.66 3.23 ± 2.80 
4 week 1.80 ± 1.53 1.81 ± 1.82*^ 
8 week 1.26 ± 1.01 2.14 ± 2.01*^ 
Values are presented as mean ± SD 
*significantly different from Pre; p<0.05 
^significantly different from ET; p<0.05 
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Figure 5: High-sensitivity C-reactive Protein 
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Fig. 5: Individual (open circles) and mean (filled diamonds) hs-CRP responses to training. A 
decrease from baseline (p<0.05) is seen at 4wk in HIIT with no further decrease at 8wk. No 
decrease from baseline (p>0.05) is seen in ET. 
* significantly different from Pre; p<0.05 
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 Maximal Aerobic Capacity 
Table 5 shows ET and HIIT data during the VO2max test. VO2, VCO2, VE, HR and 
workload increased (p<0.05) from pre-training values after 4 weeks of training in ET with no 
further increases (p>0.05) following 8 weeks of training. VCO2, VE and workload increased 
(p<0.05) in HIIT after 4 weeks of training. Following 8 weeks of training, VO2 (mL/kg/min) 
significantly increased (p<0.05) as well. The increase in VO2 with training was ~25% for both 
groups. There were no between group differences (p>0.05) in any variables at any point during 
the study. 
Table 5: VO2max Data 
 ET (n=5) HIIT (n=7) 
Time Pre 4 Weeks Post Pre 4 Weeks Post 
VO2 (L/min) 1.69 ± 0.17 2.02 ± 0.18* 2.17 ± 0.22* 2.05 ± 0.23 2.31 ± 0.22 2.32 ± 0.24 
VO2 (mL/kg/min) 22.2 ± 1.1 27.3 ± 1.9* 29.6 ± 2.8* 23.7 ± 1.5 27.0 ± 1.9 27.3 ± 1.8* 
VCO2 (L/min) 2.02 ± 0.20 2.50 ± 0.20* 2.58 ± 0.23* 2.40 ± 0.29 2.74 ± 0.28* 2.72 ± 0.27* 
VE (L/min) 77.2 ± 9.2 90.3 ± 7.1* 96.8 ± 11.2* 88.8 ± 10.4 107.2 ± 11.4* 109.9 ± 12.5* 
RER 1.17 ± 0.03 1.27 ± 0.03 1.20 ± 0.03 1.17 ± 0.04 1.19 ± 0.02 1.19 ± 0.03 
VE/VCO2 38.2 ± 1.8 36.3 ± 1.66 37.4 ± 2.40 37.4 ± 2.07 39.2 ± 1.8 40.2 ± 1.4 
VE/VO2 45.9 ± 3.7 45.1 ± 3.24 44.8 ± 3.77 43.7 ± 3.11 46.5 ± 2.5 47.4 ± 1.9 
HRpeak (bpm) 162.8 ± 2.3 174.6 ± 6.0* 175.6 ± 6.0* 175.6 ± 5.4 180.9 ± 3.9 179.4 ± 4.3 
Peak Workload 
(Watts) 
170 ± 17 200 ± 14* 205 ± 12* 182 ± 16 207 ± 15* 211 ± 14* 
Values are presented as mean ± SD 
*significantly different from Pre; p<0.05 
VO2 = aerobic capacity, VCO2 = CO2 production, VE = ventilation, RER = respiratory 
exchange ratio, VE/VCO2 = ventilatory efficiency, VE/VO2 = ventilatory equivalent
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Chapter 5 - Discussion 
 The purpose of this study was to compare the effects of high intensity interval training 
(HIIT) vs. endurance training (ET) on mean arterial blood pressure (MAP) and a marker of LGSI 
in pre-hypertensive subjects. Our data suggest that, contrary to our hypothesis, both exercise 
protocols were equally effective in decreasing MAP, systolic blood pressure (SBP), and diastolic 
blood pressure (DBP); however systemic inflammation was improved only with HIIT. Also HIIT 
was equally as effective as ET in improving aerobic capacity. Importantly, these effects seen 
with HIIT occurred with substantially less total exercise time and volume than ET. HIIT, 
therefore, may be a time efficient alternative form of training compared to the more traditional 
endurance training approach in reducing blood pressure in pre-hypertensive subjects which has 
additional health benefits of reducing systemic inflammation. 
 Mean Arterial Blood Pressure 
Eight weeks of chronic exercise training, either HIIT or ET, led to a reduction in mean 
arterial blood pressure of approximately 9%, which is in agreement with previous studies that 
used endurance trained subjects over a similar period of time as in our study (22, 120). 
Additionally, systolic (SBP), diastolic (DBP) blood pressures, and resting heart rate decreased 
with both HIIT and ET. While specific mechanisms for these improvements in blood pressure 
with exercise training were not measured in our study, previous literature allows for some insight 
to possibilities. The decrease in SBP and DBP can potentially be due to a combination of central 
cardiac and peripheral adaptations. MAP is a product of cardiac output and systemic vascular 
resistance. With regard to cardiac output, both training protocols in our study led to a resting 
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bradycardia which was anticipated. Exercise induced bradycardia has been attributed to a 
combination of an increased vagal tone (9) as well as a potential increase in plasma volume 
leading to increase in stroke volume via the Frank-Starling mechanism (25, 51). Since our study 
lasted only 8 weeks, it is unlikely that ventricular reconstruction, typically associated with 
traditional exercise training, occurred (93). However, changes seen in the periphery, according to 
Poiseuille's Law (131), are likely due to a change in the radius of the vessel. Beneficial 
adaptations leading to a decreased systemic vascular resistance are likely due to three reasons 
(46): vascular responsiveness (21, 66, 70, 78), neural (11, 43, 67), or structural adaptations (16, 
109, 110, 125). Therefore, the reduction in resting MAP we observed is consistent with previous 
reports. However, we believe our data are the first to demonstrate that HIIT was equally effective 
as ET in the decrease of MAP in pre-hypertensive subjects.  
Why was HIIT as effective as ET in reducing blood pressure? First, the reduction in 
resting heart rate due to chronic exercise was expected (112). Previous literature has shown that 
the magnitude of the decrease in HR may be dependent on the intensity of the exercise 
performed (76, 85). However, in previous studies, the total volume of work performed was not 
tightly controlled, so a conclusive stance could not be made (10, 122). One study, from Pichot et 
al. (2005), reported that decreased resting HR was attributed to increased parasympathetic nerve 
activity (PSNA) (97). The exercise that was performed by their subjects totaled 180 minutes over 
4 days was greater in duration than our protocol. Thus it is likely that a significant contributor to 
reduced MAP with HIIT was training induced brachycardia. 
A second reason for reduced blood pressure with HIIT is improved stroke volume. HIIT 
allows subjects to challenge the pumping ability of the heart more than at continuous, lower 
intensities. While one previous study found no differences in SV adaptations with interval 
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training (45), more recent research disagrees (35, 56, 87). For example, a reported decrease in 
left-ventricular (LV) end-systolic volume and increase in LV ejection fraction occurred after 12 
weeks of exercise training (136). Although the subjects were heart failure patients, in comparison 
to the control group performing ET, the benefits were greater with HIIT.  The exact mechanism 
causing the increase is not presently known however, HIIT therefore, likely led to increased 
stroke volume in our subjects. 
The third possibility for decreased MAP with HIIT is decreased systemic vascular 
resistance (SVR), an indicator of peripheral vascular function. In diseased subjects, SVR is 
greater than healthy subjects due to endothelial dysfunction (100). There are several potential 
mechanisms involved in the generation of this dysfunction, including an increase in 
inflammatory cytokines and/or decrease in nitric oxide (NO). This area of HIIT adaptations is 
largely unexplored, but NO has been shown to have a significant response (53). The exact 
modulators of NO production and synthesis are currently being investigated (41), but with regard 
to HIIT, we believe shear stress effects on NO production to be a plausible mechanism. 
Shear stress increases endothelial nitric oxide synthase (eNOS) expression and activity 
(29, 99). The increase in eNOS has been shown to cause an increase in NO-dependent 
vasodilation in hypercholesterimics, a common diagnostic measure of HTN (19). Shear stress is 
caused by fluid passing across endothelial cells. It has been shown to be dependent on intensity 
in that higher intensity exercise causes a faster flow, thus causing a greater shear rate (124, 136). 
The increase in shear rate, resulting in an increase in NO-dependent vasodilation would result in 
a sustained decrease in vascular resistance. Of the factors contributing to MAP, a decrease in 
SVR via increased shear stress would potentially have the greatest effect. We believe that this is 
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a likely key mechanism responsible for the decrease in MAP with HIIT. This theory obviously 
requires future testing to determine whether or not it occurs with HIIT. 
During HIIT, subjects pedaled at rates of ~100rpm, which also may have contributed to 
reduce BP. The effect of pedal frequency during upright exercise on exercising blood pressure 
and the baroreflex has recently been investigated. Ogoh (2007) demonstrated a resetting of the 
baroreflex dependent on pedal frequency during upright exercise (88). They reported a 
downward and leftward shift of the baroreceptor curve, allowing for lower blood pressure during 
exercise pedaling at 80 rpm when compared to 60 rpm. The authors propose that feedback from 
the cardiopulmonary baroreceptor can modulate the arterial barereptor activity. An increase in 
pedal frequency would cause an increase in central volume (106). The altering of the 
baroreceptor activity would lead to a decrease in exercising blood pressure.  
 Systemic Inflammation 
An unexpected finding was that there was no relationship was observed between baseline 
CRP levels, as a marker of systemic inflammation, and baseline MAP in either training group. 
Additionally, it was unexpected that there was no relationship between the decrease in CRP and 
decrease in MAP following training for either HIIT or ET.  This was surprising given 
epidemiological evidence that reported a relationship between these variables (36, 101, 102), 
although one study found no relationship (6). However, in previous literature, increased systemic 
inflammation was related to HTN, not necessarily prehypertension. Since our subjects were pre-
hypertensive and not diagnosed with HTN, the amount of systemic inflammation was likely less 
than those with HTN and thus there would be less opportunity for improvement with training. 
But, if that is the case, why did we see a decrease in inflammation in HIIT? The mechanism may 
be IL-6. According to Nielsen et al. (1996), IL-6 is present in higher concentrations after 
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repeated bouts of maximal exercise (86). It has also been shown that increases in IL-6 are present 
later and in lower concentrations after submaximal exercise due to a smaller amount of muscle 
mass recruited (63, 117, 118). As referenced earlier, IL-6 derived from exercising muscle is 
independent of TNF-α but still triggers other anti-inflammatory cytokines (95). Therefore, due to 
an increased amount of muscle mass recruited with HIIT, greater IL-6 may have been secreted 
from the exercising muscle which led to increases in anti-inflammatory cytokines.  
 Maximal Aerobic Capacity 
The similar improvements in maximal aerobic capacity (VO2max) with HIIT compared to 
ET in our study are consistent with previous reports and a commonly reported finding (23, 28, 
34, 58). It has been shown that increases in VO2max following training are typically intensity 
dependent (121). Recently, many studies also show that improvements in VO2max can occur with 
minimal training volume at near maximal-intensities (12-14). In addition to similar changes in 
VO2max, HIIT has been shown to increase mean power output, time to fatigue, and decrease time 
to completion in time trials highlighting the potential performance benefits associated with 
interval training (12-14, 49). To further the significance of the findings, it should be noted that 
the absolute work done during HIIT by our subjects was markedly less (~90%) than ET, 225-315 
kJ/week versus 2250-3250 kJ/week respectively. However, exercise in the severe domain can be 
uncomfortable for subjects which can act as a barrier for compliance. The protocol used in our 
study was designed to be attainable by many populations, either healthy or of compromised 
health (73). The intensity was low enough to be achievable by un-trained individuals, but over 
the 1 min intervals, high enough to achieve near maximal heart rate.  As it is well known that 
aerobic capacity is a direct indicator of one’s health (40), the relative ease of this protocol makes 
it highly attractive in disease populations and populations who are not prone to exercise.  
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 Implications 
The primary implication of this study is the ability for subjects with prehypertension to 
decrease their elevated blood pressure and systemic inflammation that may cause dysfunction in 
the arterial vasculature. The results of our study also have the potential to overcome the time 
barrier that historically limits exercise in subjects at risk for developing HTN (48). HIIT elicited 
improvements in aerobic capacity and cardiovascular health. Previous studies also confirm 
improvements in aerobic capacity, and metabolic improvements (59, 73). Therefore, this training 
protocol has the potential to be prescribed in a clinical setting to prevent the development of 
chronic diseases such as HTN or diabetes. Since we also reported a decrease in systemic 
inflammation with HIIT, the potential also exists for this exercise protocol to serve as a 
therapeutic measure for inflammatory diseases such as arthritis. Furthermore, this training 
protocol furthers the possibility for HIIT to be a staple in cardiac rehabilitation. Although limited 
research has been conducted thus far (136), the low volume and relatively lower intensity may be 
enticing to this diseased population. 
 Limitations 
Several limitations exist which may have affected our results. First, we did not monitor 
the subjects’ activity levels and diet outside of the training session. Increased leisure time 
physical activity (69) and dietary intake of sodium (8) have been shown to affect cardiovascular 
health. While our subjects were strongly encouraged to not change their daily activities during 
testing, we do not know if this was the case. Secondly, hs-CRP measurements were made only 
once during pre, 4 wks, and 8 wks due to financial reasons. Since hs-CRP can vary due to 
multiple reasons, such as acute illness with no reported symptoms, at least two tests would 
provide a more reliable value (102). However, we ensured that testing conditions were tightly 
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controlled so the changes we observed likely were due to exercise training. Also, reduction in 
body fat following training may have contributed to reduced systemic inflammation. While body 
weight didn’t change with training in our subjects, we don’t know if changes in lean body mass 
or fat mass occurred. Finally, human error may have affected the measurement of blood pressure, 
which was manually taken. However, in an attempt to ensure accurate assessment, blood 
pressure measurements were periodically validated by an independent investigator. Furthermore, 
the change in MAP with training that we observed is consistent with previous literature (81). 
 Future Directions 
To our knowledge this is the first study to investigate the effects of HIIT on MAP in 
subjects with prehypertension. The exercise protocol we followed has been used in prior studies 
to examine the effects on muscle metabolism (59, 73). With positive outcomes in both previous 
and the present study, we would suggest further investigation on the stimulus responsible for 
these outcomes. We have speculated on possible mechanisms involved, but direct measurement 
is necessary to gain a better understanding. It would be novel to explore resting baroreceptor 
activity after chronic training at high pedal frequency with HIIT.  In regards to changes in 
systemic inflammation, it would be worthwhile to investigate other markers of inflammation, 
specifically IL-6. It is important to understand any differences seen using the same time pattern 
at different intensities, or if slightly modifying the work-to-rest ratio would change the results. It 
is also important to test differnt subject populations under this protocol. The current study used 
pre-hypertensive, but not hypertensive, population. In order for this protocol to be prescribed 
clinically, experiments will need to be performed using populations with HTN. More 
importantly, if this protocol is to be used as a time-efficient alternative to the ACSM 
recommendations, it is necessary to gain an understanding of the effects seen during a longer 
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prescribed time. To our knowledge, this is the longest application of this specific training 
protocol. However, it is necessary to look at the effects seen using this protocol for 6 months, a 
year, etc. Also, as childhood obesity has become a recent concern (4), the comorbidity of obesity 
is also a concern (i.e. diabetes, HTN) (83). It would be a novel approach to apply this exercise 
protocol to overweight/obese children in an attempt to reverse some negative health outcomes 
seen as this protocol has shown positive metabolic and, in our study, cardiovascular adaptations.  
 Conclusion 
Chronic exercise training is known to help to reduce HTN. Interval training has been 
shown in recent years to be a healthy, time-efficient alternative to traditional endurance exercise 
training in regulation of glucose and insulin levels as well as improve gas exchange at the level 
of the tissue. Results from our study suggest that high intensity interval training can also be as 
effective as more traditional endurance training in reducing blood pressure in subjects with 
prehypertension. An additional benefit with HIIT above ET is that HIIT may be more effective 
than ET in reducing systemic inflammation, which may be contributing to HTN. Further research 
is needed to determine the specific mechanistic basis for these improvements and their 
implications to populations already effected by HTN.  
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